NLRP3 and atherosclerosis: Furthermore, studies using bone marrow-transplanted mice, lentivirus-mediated NLRP3 gene silencing or the selective NLRP3 inhibitor MCC950 in apoE−/− mice have provided direct evidence that the NLRP3 inflammasome contributes to the progression of atherosclerosis [69].